There are 2949 resources available
Pre-habilitation at the time of diagnosis or relapse: As important as post-treatment rehabilitation?
Presenter: Florian Strasser
Session: The cancer journey: The importance of getting the right physical and mental support
Resources:
Slides
Webcast
Patients navigating patients: When the best support comes from a peer
Presenter: Hulda Hjalmardóttir
Session: The cancer journey: The importance of getting the right physical and mental support
Resources:
Slides
Webcast
Synthetic lethality screens to identify genes that control the response of cancer cells to DNA damaging agents
Presenter: Thanos Halazonetis
Session: Targeting DNA damage response pathways in cancer
Resources:
Slides
Webcast
Mutation signatures as biomarkers for selecting treatment options
Presenter: Serena Nik-Zainal
Session: Targeting DNA damage response pathways in cancer
Resources:
Slides
Webcast
Nucleolar stress as a cancer driver (and a vulnerability)
Presenter: Oscar Fernandez-Capetillo
Session: Targeting DNA damage response pathways in cancer
Resources:
Slides
Webcast
Which trials are missing in mRCC?
Presenter: Bernard Escudier
Session: Are we ready for another big step in kidney and bladder cancer?
Resources:
Slides
Webcast
From bench to bedside: Future perspectives of immunotherapy combinations in bladder cancer
Presenter: Andrea Necchi
Session: Are we ready for another big step in kidney and bladder cancer?
Resources:
Slides
Webcast
Which trials are missing in bladder cancer?
Presenter: Thomas Powles
Session: Are we ready for another big step in kidney and bladder cancer?
Resources:
Slides
Webcast
From bench to bedside: Future perspectives of immunotherapy combinations in mRCC
Presenter: Viktor Gruenwald
Session: Are we ready for another big step in kidney and bladder cancer?
Resources:
Slides
Webcast
Open, welcome and introduction of the Speaker
Presenter: Daniel Peeper
Session: Linking genetic alterations to dependencies for new cancer therapeutics
Resources:
Webcast